StreetAlpha.app
Home › Stocks › OGN

Organon & Co. (OGN)

Healthcare
$13.89
▼ −0.14%
LAST CLOSE · NOV 20

Organon makes women's health drugs, biosimilars and established brands sold to wholesalers, hospitals and healthcare providers. It last closed at $13.89 on Nov 20, down 0.14% on the day. For the quarter ended Sep 2026, OGN reported EPS of $0.60 on revenue of $1.57B, with revenue down 1.7% from a year ago. Over its last 8 reports the stock moved an average of 10.8% the session after earnings. Over the last 12 months OGN insiders bought $353K of stock on the open market and sold $200K, according to SEC Form 4 filings.

AI Auto Pilots
Is OGN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OGN.

Key Stats

Last 12 months
Results
Revenue
$6.1B
−3.2% vs a year ago
Net income
$213.0M
−57.5% vs a year ago
EPS (diluted)
$0.78
−59.2% vs a year ago
Free cash flow
$675.0M
11.1% margin
Valuation
Market cap
$3.6B
262.6M shares
P/E
17.8
Price over 12 month EPS
Price to sales
0.6
Market cap over revenue
Dividend yield
0.58%
$0.08 a share over 12 months
Balance sheet
Cash & equivalents
$1.5B
At Sep 30
Debt
$8.6B
At Sep 30
Shareholder equity
$1.2B
Shares outstanding
262.6M
At Oct 23
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $6.3B$6.3BFY2021FY2022: $6.2B$6.2BFY2022FY2023: $6.3B$6.3BFY2023FY2024: $6.4B$6.4BFY2024FY2025: $6.2B$6.2BFY2025

From OGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Last report
Apr 30
2026 · next date not set yet
Reported EPS
$0.60
Quarter ended Sep 2026
Year ago EPS
$0.61
−1.6% on a GAAP basis
Revenue
$1.57B
−1.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.41Dec '24Mar 2025: $0.33Mar '25Jun 2025: $0.56Jun '25Sep 2025: $0.61Sep '25Dec 2025: -$0.78Dec '25Mar 2026: $0.55Mar '26Jun 2026: $0.40Jun '26Sep 2026: $0.60Sep '26Latest $0.60
Revenue by quarter
Dec 2024: $1.59BDec '24Mar 2025: $1.51BMar '25Jun 2025: $1.59BJun '25Sep 2025: $1.60BSep '25Dec 2025: $1.51BDec '25Mar 2026: $1.46BMar '26Jun 2026: $1.56BJun '26Sep 2026: $1.57BSep '26Latest $1.57B
How OGN moved after its last 8 reports
Average move the session after a report ±10.8%
Apr 30, 2026Time not announced−0.7%
Feb 12, 2026Time not announced−8.2%
Nov 10, 2025Time not announced+13.7%
Aug 5, 2025Time not announced−13.1%
May 1, 2025Time not announced−26.9%
Feb 13, 2025Time not announced+11.0%
Oct 31, 2024Time not announced+4.7%
Aug 6, 2024Time not announced−7.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on OGNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on OGN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on OGN

Technical Analysis

OGN · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 0% above its 20 day and 1% above its 50 day average. It is 14% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 61). The nearest support is the Pivot S1 at $13.88, and the nearest resistance the Pivot at $13.90.

Short trendNeutral
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 0.3%/day
Key levels
$13.9452 week high+0.4%
$13.90Pivot R1+0.1%
$13.90Pivot+0.1%
$13.89Last close
$13.88Pivot S1−0.1%
$13.8520 day average−0.3%
$13.7850 day average−0.8%
$13.78Swing low (Nov 6)−0.8%
$13.70100 day average−1.4%
$11.89200 day average−14.4%
$5.6952 week low−59.0%
Indicators
RSI (14)60.52Strong, overbought above 70Neutral
MACD0.04Below its signal lineBearish
Stochastic83.3Near the top of its rangeOverbought
ADX (14)39.0Trending up
Williams %R-31.3Oversold below −80, overbought above −20Neutral
CCI (20)77.4Oversold below −100, overbought above 100Neutral
Rate of change+0.1%Change over 10 sessionsBullish
ATR (14)$0.04Typical daily range, 0.3% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for OGN

What happened before

See how OGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow OGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How OGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for OGNHow many large options trades hit OGN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

OGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼200 buying vs 261 selling
  • ▲Held by funds +3.1 pts
  • ▼Funds holding -28
  • ▲Superinvestors: 2 added, 1 cut
  • ▼Put/call 1.63 to 3.51
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding608636−4.4%
In funds' top 10660.0%
Held by funds86.3%83.3%+3.1 pts
New / increased52 / 148111 / 118−12.7%
Reduced / sold out188 / 73194 / 92−8.7%
Put/call ratio3.511.63+115.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See OGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

OGN Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$353K1 buy · 1 insider
Sold$200K1 sale · 1 insider
2026-05 bought $353K2026-08 sold $200KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 5Juliana Papa DrinaneHead of Mfg & SupplySale14,761$13.57$200K
May 6Lynette HolzbaurSVP and Corporate ControllerBuy26,448$13.35$353K
Nov 12, 2025Carrie Smith CoxExecutive ChairBuy65,400$7.67$502K
May 14, 2025Carrie Smith CoxDirectorBuy12,469$8.07$101K
May 7, 2025Aaron FalcioneChief Human Resources OfficerBuy5,500$8.77$48K
May 6, 2025Daniel KarpExecutive VP, Corp. Dev.Buy3,500$8.24$29K
Every insider buy and sale for OGN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See OGN insider trades →

From SEC Form 4 filings by OGN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OGN is in one of them and how their past OGN trades turned out.

OGN in the AI portfolios
Loading…

OGN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered OGN in an article yet. Here's the latest on the wider market.

OGN in the news

OGN Congress Trades

All congress trades →
Trades, 12 months
3
Buys
0
0%
Sells
3
100%
People
2
Last filed Aug 10
Who traded OGN · since 2021
Latest 4 filings
$1K – $15KTraded Aug 5, 2026Filed Aug 10, 2026
$1K – $15KTraded Aug 5, 2026Filed Aug 10, 2026
$1K – $15KTraded Jul 10, 2025Filed Nov 24, 2025
$1K – $15KTraded Jun 28, 2021Filed Jul 9, 2021
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell$1K – $15KAug 5, 2026Aug 10, 20265 d
Kevin HernR · OKSell$1K – $15KAug 5, 2026Aug 10, 20265 d
Gary C PetersD · MISell$1K – $15KJul 10, 2025Nov 24, 2025137 d
John HickenlooperD · COSell$1K – $15KJun 28, 2021Jul 9, 202111 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Organon &

Organon is a healthcare company based in Jersey City, New Jersey, that makes prescription medicines. Its women's health line includes contraceptive products such as an implant and a vaginal ring, along with fertility treatments. It also sells biosimilars, which are versions of biologic drugs, and established brands in areas such as cardiovascular, respiratory and dermatology care. Customers include drug wholesalers, retailers, hospitals, government agencies and managed healthcare providers, and products are sold in more than 140 countries.

Headquarters
Jersey City, NJ
Founded
1923